Calma, Baby Girl -.
HRN: 23-76-57 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/22/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/22/2023
10/29/2023
IV
40mg
Q24H
Thickly MSAF
Checking Final Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes